MARKET

MTFB

Motif Bio
MTFB
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-2.1344
-
-3.2311
50,966,896.26
The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 26)
Benzinga · 11/27/2019 12:26
The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.)
Benzinga · 11/26/2019 13:06
The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Nov. 7.)
Benzinga · 11/08/2019 13:16
The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 28.)
Benzinga · 10/29/2019 11:32
The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 14.)
Benzinga · 10/15/2019 11:50
The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
The following is a roundup of top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 10.)
Benzinga · 10/11/2019 12:14
The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
The following is a roundup of top developments in the biotech space over the last 24 hours.  None of the NYSE or Nasdaq-listed biotech stocks hit 52-week highs on Tuesday. Down In The Dumps (Biotech stocks that hit 52-week lows Oct. 8.)
Benzinga · 10/09/2019 11:58
The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2)
Benzinga · 10/03/2019 11:34
More
No Data
Learn about the latest financial forecast of MTFB. Analyze the recent business situations of Motif Bio through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
50.00%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average MTFB stock price target is 3.500 with a high estimate of 5.00 and a low estimate of 2.000.
High5.00
Average3.500
Low2.000
Current 0.1050
EPS
Actual
Estimate
-0.06-0.04-0.03-0.01
Q1 2016
Q2 2016
Institutional Holdings
Institutions: 6
Institutional Holdings: 1.42M
% Owned: 0.29%
Shares Outstanding: 485.35M
TypeInstitutionsShares
Increased
2
34.84K
New
3
261.56K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.48%
Pharmaceuticals & Medical Research
+0.70%
Key Executives
Non-Executive Chairman
Richard Morgan
Chief Executive Officer/Executive Director
Graham Lumsden
Chief Financial Officer/Non-Executive Director
Jonathan Gold
Vice President
Stephanie Noviello
Vice President
Rajesh Shukla
Executive Director
Robert Bertoldi
Other
David Huang
Secretary
Stephen Austin
Non-Executive Director
Craig Albanese
Non-Executive Director
Charlotta Ginman-Jones
Non-Executive Director
Zaki Hosny
Non-Executive Director
Mary Polan
No Data
No Data

Webull offers kinds of Motif Bio stock information, including NASDAQ:MTFB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTFB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MTFB stock methods without spending real money on the virtual paper trading platform.